Summary
Health Secretary Robert F. Kennedy Jr. has decided to stop $500 million in funding for mRNA vaccine development in the United States. This decision affects 22 vaccine projects by companies like Pfizer and Moderna. Kennedy pointed to concerns about mRNA technology, but health experts worry that this move could affect the U.S.'s ability to handle future pandemics.
Key Facts
- The U.S. plans to cancel $500 million in funding for developing mRNA vaccines targeting viruses like the flu and COVID-19.
- This decision impacts 22 projects led by major pharmaceutical companies, including Pfizer and Moderna.
- Robert F. Kennedy Jr., a known vaccine skeptic, announced the funding cut, citing risks he perceives with mRNA technology.
- Health experts, like Paul Offit, argue that mRNA vaccines were crucial in controlling the COVID-19 pandemic because they are developed quickly.
- Kennedy claims the data show mRNA vaccines do not effectively protect against viruses as they mutate.
- Dr. Offit countered by saying mRNA vaccines are safe and help prevent severe illness.
- The Biomedical Advanced Research and Development Authority (BARDA) will focus on vaccines with better safety records.
- Kennedy has made several changes in the U.S. health department, including altering vaccine regulation and committee memberships.
